EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Endemic Human Coronavirus Antibody Levels Are Unchanged after Convalescent or Control Plasma Transfusion for Early Outpatient COVID-19 Treatment

Andrew H Karaba iD, Trevor S Johnston, Evan Beck, Oliver Laeyendecker iD, Andrea L Cox, Sabra L Klein iD, David J Sullivan iD, COVID-19 Serologic Studies Consortium

mBio · 2023

DOI: 10.1128/mbio.03287-22 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift mBio, 2023. Verfasst von Andrew H Karaba und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The relevance of preexisting immunity to the four endemic human coronaviruses in the first week of COVID-19 illness on the outcome of COVID-19 progression stems from the high prevalence of the ehCoV and SARS-CoV-2 coronaviruses. The question has been raised of whether therapeutic convalescent plasma or control plasma containing ehCoV antibodies might alter the outcome of COVID-19 progression to hospitalization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansSARS-CoV-2Prospective StudiesBlood Component TransfusionCOVID-19 Drug TreatmentOutpatientsPlasmaCOVID-19 SerotherapyAntibodies, ViralSpike Glycoprotein, Coronavirus

Stichwörter der Autor:innen

COVID-19SARS-CoV-2endemic human coronavirusesplasma transfusion

Substanzen

Antibodies, ViralSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Autor:innen und Institutionen

  • Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, Baltimore, Maryland, USA.
  • The Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

ORCID-Profile: Andrew H Karaba, Oliver Laeyendecker, Sabra L Klein, David J Sullivan

Förderung

  • NIAID NIH HHS
  • NCI NIH HHS
  • NCATS NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases
  • U.S. Department of Defense

Zitieren

APA

Karaba, A. H., Johnston, T. S., Beck, E., Laeyendecker, O., Cox, A. L., Klein, S. L., Sullivan, D. J., & COVID-19 Serologic Studies Consortium (2023). Endemic Human Coronavirus Antibody Levels Are Unchanged after Convalescent or Control Plasma Transfusion for Early Outpatient COVID-19 Treatment. mBio. https://doi.org/10.1128/mbio.03287-22

Vancouver

Karaba AH, Johnston TS, Beck E, Laeyendecker O, Cox AL, Klein SL, et al. Endemic Human Coronavirus Antibody Levels Are Unchanged after Convalescent or Control Plasma Transfusion for Early Outpatient COVID-19 Treatment. mBio. 2023. doi:10.1128/mbio.03287-22

BibTeX
@article{Karaba2023,
  author = {Karaba, Andrew H and Johnston, Trevor S and Beck, Evan and Laeyendecker, Oliver and Cox, Andrea L and Klein, Sabra L and Sullivan, David J and COVID-19 Serologic Studies Consortium, COVID-19 Serologic Studies Consortium},
  title = {Endemic Human Coronavirus Antibody Levels Are Unchanged after Convalescent or Control Plasma Transfusion for Early Outpatient COVID-19 Treatment},
  journal = {mBio},
  year = {2023},
  doi = {10.1128/mbio.03287-22}
}
Kostenlos starten →